Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/346720
Type: Artigo
Title: Influence of pH and ozone dose on sulfaquinoxaline ozonation
Author: Urbano, Vanessa Ribeiro
Maniero, Milena Guedes
Perez-Moya, Montserrat
Guimaraes, Jose Roberto
Abstract: Sulfaquinoxaline (SQX) is an antimicrobial of the sulfonamides class. Usually employed in veterinary medicine, this contaminant of emerging concern has been found in superficial and groundwater and its consequences for the environment and human health are not completely known. In this study, SQX (C0 = 500 μg L−1, 1 L) degradation by an ozonation process at pH 3, 7, and 11 was evaluated. Ozonation was effective in degrading SQX: efficiency exceeding 99% was obtained applying an ozone dose of 2.8 mg L−1 at pH 3. Assays were performed according to a 22 design of experiments (DOE) with star points and three central points for statistical validity. Minimum and maximum levels were set at 3 and 11 for pH, and 0 and 11.5 mg L−1 for applied ozone dose. There was no significant interaction between these variables, and the pH value played the most important role in terms of contaminant degradation. In relation to toxicity, samples ozonated at pH 3 did not inhibit the luminescence of the bacteria, even though different intermediates were formed and identified by mass spectra. At pH 7, inhibition of luminescence remained almost constant (at around 30%) according to ozonation time or ozone dose. However, the hydroxyl radical, the major oxidant at pH 11, was responsible for the formation of toxic intermediates
Subject: Sulfonamidas
Oxidação
Country: Reino Unidoq
Editor: Elsevier
Rights: Fechado
Identifier DOI: 10.1016/j.jenvman.2016.08.019
Address: https://www.sciencedirect.com/science/article/pii/S0301479716305576
Date Issue: 2017
Appears in Collections:FEC - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
000403864500016.pdf741.48 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.